Price ₹431 below 50 SMA ₹436, above 200 SMA ₹420.
Iveco posted €74M Q1 loss; acquisition expected to close Q3 2026.
Iveco Q1 net loss of €74M raises earnings dilution risks for TMCV.
Revenue grew 24.6% over five quarters to ₹21,847 Cr in Dec 2025.
50-day SMA rolled over from ₹458.51 to ₹436.06, price below it.
Valuation at 36.5x P/E is indefensible for cyclical CV stock.
Trailing P/E is 56x, not 36x, based on ₹705 crore net profit.
Trailing P/E is ~56x, not 36.5x, with ₹1.58 lakh Cr market cap.